Yusuf Hamied
Health care

Yusuf Hamied Net Worth

Yusuf Hamied is the non-executive chairman of Cipla, a $2 billion generics maker known for its portfolio of affordable generic drugs, such as for HIV/AIDS. He inherited the company in 1972 from his father, who founded Cipla in 1935 with the aim of making India self-sufficient in essential medicines. Last September, Cipla appointed a new CEO and named Hamied's niece Samina Vaziralli as executive vice chairman. The company is expanding overseas, notably in South Africa, where it is building a new $90 million plant to make biosimilar drugs in Durban. Cipla was also one of a group of companies that successfully bid for drugs divested by Israel's Teva Pharmaceuticals.
Yusuf Hamied is a member of Health care

Age, Biography and Wiki

Birth Day July 25, 1936
Birth Place Mumbai, India, India
Age 87 YEARS OLD
Birth Sign Leo
Residence Mumbai, India
Alma mater Christ's College, Cambridge
Title Former chairman, Cipla
Successor M. K. Hamied
Spouse(s) Farida
Children none
Parent(s) Khwaja Abdul Hamied
Awards Padma Bhushan

💰 Net worth: $1.8 Billion (2024)

Yusuf Hamied, renowned as a healthcare luminary in India, is projected to have a net worth of $1.8 billion in the year 2024. His significant wealth can be attributed to his relentless dedication and contribution to the pharmaceutical industry. As the chairman of Cipla, one of India's leading pharmaceutical companies, Hamied has played a pivotal role in making essential medicines more accessible to the masses. His commitment to providing affordable healthcare solutions has not only revolutionized the Indian healthcare sector but has also positively impacted millions of lives worldwide. With his vast wealth and unwavering commitment, Yusuf Hamied continues to be a driving force in the quest for equitable healthcare.

2010 $2 Billion
2011 $1.1 Billion
2012 $1.1 Billion
2013 $1.2 Billion
2014 $1.1 Billion
2015 $1.8 Billion
2016 $1.3 Billion
2017 $1.5 Billion
2018 $1.54 Billion

Famous Quotes:

Dr. Yusuf K. Hamied, chairman of the Indian drug giant Cipla Ltd., electrified the global health community a decade ago when he said he could produce cocktails of AIDS medicines for $1 per day — a fraction of the price charged by branded pharmaceutical companies. That price has since fallen to 20 cents per day, and more than six million people in the developing world now receive treatment, up from little more than 2,000 in 2001.

Biography/Timeline

2005

He was awarded the Padma Bhushan, India's third highest civilian honour by Government of India in 2005.

2009

In 2009 the Yusuf Hamied Centre was opened at Christ's College, Cambridge. The centre features a bronze portrait bust of Hamied by fellow Christ's College alumnus, Anthony Smith.

2011

In September 2011, in a piece about how he was trying to radically lower costs of biotech drugs for cancer, diabetes and other noncommunicable diseases, The New York Times wrote of Hamied:

2012

Hamied was awarded the 'CNN-IBN Indian of the Year' in the category of Business by CNN-IBN in 2012 "for taking on multinational pharma companies and making some of the essential drugs more affordable to the masses in the developing countries. In late 2013, he was also named one of the India's "25 Greatest Global Living Legends" by news broadcaster NDTV. He was also recently interviewed for the Creating Emerging Markets project at the Harvard Business School, discussing at length his strategies to provide AIDS treatments and other drugs to help treat poor people in the developing world.

2013

Hamied's role in the battle for mass antiretroviral treatment in Africa is portrayed in the documentary Fire in the Blood (2013 film). In its review of the film, India Today noted that "the story of Yusuf Hamied will make every Indian proud as he was the only man who decided to walk against the tide and sell drugs to save lives without focusing on profits."

2016

As of January 2016, Yusuf Hamied has a net worth of US$1.45 billion.

Some Yusuf Hamied images

About the author

Lisa Scholfield

As a Senior Writer at Famous Net Worth, I spearhead an exceptional team dedicated to uncovering and sharing the stories of pioneering individuals. My passion for unearthing untold narratives drives me to delve deep into the essence of each subject, bringing forth a unique blend of factual accuracy and narrative allure. In orchestrating the editorial workflow, I am deeply involved in every step—from initial research to the final touches of publishing, ensuring each biography not only informs but also engages and inspires our readership.